Targeted Genetics is a leader in the preclinical, clinical and regulatory development of AAV-based therapies and in the manufacture of AAV-vectors. Through its research and development activities to date, the Company has acquired expertise and intellectual property related to a variety of additional viral gene delivery technologies. In the preclinical and clinical development of these vectors and the implementation of processes to manufacture them in a cost-effective manner, the Company has created important defining competencies that differentiate Targeted Genetics from its competitors.
|
